3-Chloro-2-[(E)-2-(phenylmethylidene)hydrazin-1-yl]-5-(trifluoromethyl)pyridine

Catalog No. :
ACWINX449
CAS No. :
339029-71-9
Molecular Formula :
C13H9ClF3N3
Molecular Weight :
299.68

IUPAC Name:(E)-2-(2-benzylidenehydrazineyl)-3-chloro-5-(trifluoromethyl)pyridine

3-Chloro-2-[(E)-2-(phenylmethylidene)hydrazin-1-yl]-5-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$566.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-2-[(E)-2-(phenylmethylidene)hydrazin-1-yl]-5-(trifluoromethyl)pyridine
IUPAC Name(E)-2-(2-benzylidenehydrazineyl)-3-chloro-5-(trifluoromethyl)pyridine
MDL No.MFCD00232264
Molecular FormulaC13H9ClF3N3
Molecular Weight299.68
SMILESFC(C1=CN=C(N/N=C/C2=CC=CC=C2)C(Cl)=C1)(F)F
InChI KeyZMLUSNKADQBTFL-FBCYGCLPSA-N
SynonymBENZENECARBALDEHYDE N-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]HYDRAZONE;Benzaldehyde, 2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]hydrazone
CAS No.339029-71-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWINX449 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNMSB507 route compound structure diagram
    ACNMSB50789570-82-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWINX449 route product structure diagram
    ACWINX449339029-71-9
Inquiry

2. ACWINX449 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWJIK401 route compound structure diagram
    ACWJIK4015281-18-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWINX449 route product structure diagram
    ACWINX449339029-71-9
Inquiry

Comments (0)